USA Traveler's Diarrhea Therapeutics Market Professional Research Report 2022-2027, Segmented by Players, Types, End-Users in Major Regions

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • Traveler's diarrhea (TD) is a stomach and intestinal infection. TD is defined as the passage of unformed stool (one or more by some definitions, three or more by others) while traveling. It may be accompanied by abdominal cramps, nausea, fever, and bloating. Occasionally bloody diarrhea may occur. Most travelers recover within four days with little or no treatment. About 10% of people may have symptoms for a week. Traveler’s diarrhea is the leading cause of illness among international travelers to developing countries. Enterotoxigenic Escherichia coli (ETEC) bacteria are the primary cause of this disease. Among the estimated 65 million travelers from industrialized countries to high-risk areas in the developing world, as many as 50% may experience at least one TD episode during their journey. ETEC is usually responsible for 22-60% of all TD cases in both civilian and military groups or about 7-18 million cases per year. ETEC is also a major cause of diarrheal disease in children living in countries endemic for ETEC, leading to over 400 million diarrheal episodes and approximately 300,000 deaths each year.

    The classification of Traveler’s Diarrhea Therapeutics includes Immunization, Non-antibiotic Agents, Antibiotics, Anti-Motility Agents, Other. And the proportion of Non-antibiotic Agents in 2017 is about 36%, and And the proportion of Anti-Motility Agents in 2017 is about 20%.

    This report offers an overview of the market trends, drivers, and barriers with respect to the USA Traveler's Diarrhea Therapeutics market. It also provides a detailed overview of the market of different regions across West USA, South USA, Middle West USA, Northeast USA. The report deeply analyzes type and application in the USA Traveler's Diarrhea Therapeutics market. Detailed analysis of key players, along with key growth strategies adopted by Traveler's Diarrhea Therapeutics industry, the PEST and SWOT analysis are also included. In short, the report will provide a comprehensive view of the industry's development and features.

    By Player:

    • PaxVax

    • Valneva

    • Shanghai United Cell

    • P&G

    • Johnson & Johnson

    • Livzon

    • Salix Pharmaceuticals

    • Immuron

    • Otsuka Pharma

    By Type:

    • Immunization

    • Non-antibiotic Agents

    • Antibiotics

    • Anti-Motility Agents

    • Other

    By End-User:

    • Adult Traveler's Diarrhea

    • Children Traveler's Diarrhea

    By Region:

    • West USA

    • South USA

    • Middle West USA

    • Northeast USA

  • TABLE OF CONTENT

    1 Report Overview

    • 1.1 Product Definition and Scope

    • 1.2 PEST (Political, Economic, Social and Technological) Analysis of Traveler's Diarrhea Therapeutics Market

    • 1.3 Market Segment by Type

      • 1.3.1 USA Traveler's Diarrhea Therapeutics Market Size and Growth Rate of Immunization from 2016 to 2027

      • 1.3.2 USA Traveler's Diarrhea Therapeutics Market Size and Growth Rate of Non-antibiotic Agents from 2016 to 2027

      • 1.3.3 USA Traveler's Diarrhea Therapeutics Market Size and Growth Rate of Antibiotics from 2016 to 2027

      • 1.3.4 USA Traveler's Diarrhea Therapeutics Market Size and Growth Rate of Anti-Motility Agents from 2016 to 2027

      • 1.3.5 USA Traveler's Diarrhea Therapeutics Market Size and Growth Rate of Other from 2016 to 2027

    • 1.4 Market Segment by Application

      • 1.4.1 USA Traveler's Diarrhea Therapeutics Market Size and Growth Rate of Adult Traveler's Diarrhea from 2016 to 2027

      • 1.4.2 USA Traveler's Diarrhea Therapeutics Market Size and Growth Rate of Children Traveler's Diarrhea from 2016 to 2027

    • 1.5 Market Segment by Regions

      • 1.5.1 West USA Traveler's Diarrhea Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.2 South USA Traveler's Diarrhea Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.3 Middle West USA Traveler's Diarrhea Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

      • 1.5.4 Northeast USA Traveler's Diarrhea Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    2 Market Trends and Competitive Landscape

    • 2.1 Market Trends and Dynamics

      • 2.1.1 Market Challenges and Restraints

      • 2.1.2 Market Opportunities and Potentials

      • 2.1.3 Mergers and Acquisitions

    • 2.2 Competitive Landscape Analysis

      • 2.2.1 Industrial Concentration Analysis

      • 2.2.2 Porter's Five Forces Analysis of the Industry

      • 2.2.3 SWOT Analysis for New Entrants

    • 2.3 Coronavirus (COVID-19) Distribution and its Impact on the Industry

    3 Segmentation of Traveler's Diarrhea Therapeutics Market by Types

    • 3.1 Products Development Trends of Different Types

    • 3.2 Products Types of Major Vendors

    • 3.3 Competitive Landscape Analysis of Different Types

    • 3.4 Market Size of Traveler's Diarrhea Therapeutics by Major Types

      • 3.4.1 Market Size and Growth Rate of Immunization

      • 3.4.2 Market Size and Growth Rate of Non-antibiotic Agents

      • 3.4.3 Market Size and Growth Rate of Antibiotics

      • 3.4.4 Market Size and Growth Rate of Anti-Motility Agents

      • 3.4.5 Market Size and Growth Rate of Other

    4 Segmentation of Traveler's Diarrhea Therapeutics Market by End-Users

    • 4.1 Downstream Client Analysis by End-Users

    • 4.2 Competitive Landscape Analysis of Different End-Users

    • 4.3 Market Potential Analysis of Different End-Users

    • 4.4 Market Size of Traveler's Diarrhea Therapeutics by Major End-Users

      • 4.4.1 Market Size and Growth Rate of Traveler's Diarrhea Therapeutics in Adult Traveler's Diarrhea

      • 4.4.2 Market Size and Growth Rate of Traveler's Diarrhea Therapeutics in Children Traveler's Diarrhea

    5 Market Analysis by Regions

    • 5.1 USA Traveler's Diarrhea Therapeutics Production Analysis by Regions

    • 5.2 USA Traveler's Diarrhea Therapeutics Consumption Analysis by Regions

    • 5.3 Coronavirus (COVID-19) Impact on USA Economy

    6 West USA Traveler's Diarrhea Therapeutics Landscape Analysis

    • 6.1 West USA Traveler's Diarrhea Therapeutics Landscape Analysis by Major Types

    • 6.2 West USA Traveler's Diarrhea Therapeutics Landscape Analysis by Major End-Users

    7 South USA Traveler's Diarrhea Therapeutics Landscape Analysis

    • 7.1 South USA Traveler's Diarrhea Therapeutics Landscape Analysis by Major Types

    • 7.2 South USA Traveler's Diarrhea Therapeutics Landscape Analysis by Major End-Users

    8 Middle West USA Traveler's Diarrhea Therapeutics Landscape Analysis

    • 8.1 Middle West USA Traveler's Diarrhea Therapeutics Landscape Analysis by Major Types

    • 8.2 Middle West USA Traveler's Diarrhea Therapeutics Landscape Analysis by Major End-Users

    9 Northeast USA Traveler's Diarrhea Therapeutics Landscape Analysis

    • 9.1 Northeast USA Traveler's Diarrhea Therapeutics Landscape Analysis by Major Types

    • 9.2 Northeast USA Traveler's Diarrhea Therapeutics Landscape Analysis by Major End-Users

    10 Major Players Profiles

      • 10.1 PaxVax

        • 10.1.1 PaxVax Company Profile and Recent Development

        • 10.1.2 Market Performance

        • 10.1.3 Product and Service Introduction

      • 10.2 Valneva

        • 10.2.1 Valneva Company Profile and Recent Development

        • 10.2.2 Market Performance

        • 10.2.3 Product and Service Introduction

      • 10.3 Shanghai United Cell

        • 10.3.1 Shanghai United Cell Company Profile and Recent Development

        • 10.3.2 Market Performance

        • 10.3.3 Product and Service Introduction

      • 10.4 P&G

        • 10.4.1 P&G Company Profile and Recent Development

        • 10.4.2 Market Performance

        • 10.4.3 Product and Service Introduction

      • 10.5 Johnson & Johnson

        • 10.5.1 Johnson & Johnson Company Profile and Recent Development

        • 10.5.2 Market Performance

        • 10.5.3 Product and Service Introduction

      • 10.6 Livzon

        • 10.6.1 Livzon Company Profile and Recent Development

        • 10.6.2 Market Performance

        • 10.6.3 Product and Service Introduction

      • 10.7 Salix Pharmaceuticals

        • 10.7.1 Salix Pharmaceuticals Company Profile and Recent Development

        • 10.7.2 Market Performance

        • 10.7.3 Product and Service Introduction

      • 10.8 Immuron

        • 10.8.1 Immuron Company Profile and Recent Development

        • 10.8.2 Market Performance

        • 10.8.3 Product and Service Introduction

      • 10.9 Otsuka Pharma

        • 10.9.1 Otsuka Pharma Company Profile and Recent Development

        • 10.9.2 Market Performance

        • 10.9.3 Product and Service Introduction

    The List of Tables and Figures

    • Figure Product Picture

    • Figure USA Traveler's Diarrhea Therapeutics Market Size and Growth Rate of Immunization from 2016 to 2027

    • Figure USA Traveler's Diarrhea Therapeutics Market Size and Growth Rate of Non-antibiotic Agents from 2016 to 2027

    • Figure USA Traveler's Diarrhea Therapeutics Market Size and Growth Rate of Antibiotics from 2016 to 2027

    • Figure USA Traveler's Diarrhea Therapeutics Market Size and Growth Rate of Anti-Motility Agents from 2016 to 2027

    • Figure USA Traveler's Diarrhea Therapeutics Market Size and Growth Rate of Other from 2016 to 2027

    • Figure Market Share by Type in 2016

    • Figure Market Share by Type in 2020

    • Figure Market Share by Type in 2027

    • Figure USA Traveler's Diarrhea Therapeutics Market Size and Growth Rate of Adult Traveler's Diarrhea from 2016 to 2027

    • Figure USA Traveler's Diarrhea Therapeutics Market Size and Growth Rate of Children Traveler's Diarrhea from 2016 to 2027

    • Figure Market Share by End-User in 2016

    • Figure Market Share by End-User in 2020

    • Figure Market Share by End-User in 2027

    • Figure West USA Traveler's Diarrhea Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure South USA Traveler's Diarrhea Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Middle West USA Traveler's Diarrhea Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Northeast USA Traveler's Diarrhea Therapeutics Consumption Market Size and Growth Rate from 2016 to 2027

    • Figure Development Trends and Industry Dynamics of Traveler's Diarrhea Therapeutics Industry

    • Figure Market Challenges and Restraints

    • Figure Market Opportunities and Potentials

    • Table Mergers and Acquisition

    • Figure Market Share of TOP 3 Players in 2019

    • Figure Market Share of TOP 5 Players in 2019

    • Figure Market Share of TOP 6 Players from 2016 to 2020

    • Figure Porter's Five Forces Analysis

    • Figure New Entrant SWOT Analysis

    • Figure Coronavirus (COVID-19) Distribution Map of USA

    • Table Coronavirus (COVID-19) Impact on the Industry

    • Figure Specifications of Different Types of Traveler's Diarrhea Therapeutics

    • Figure Development Trends of Different Types

    • Table Products Types of Major Vendors

    • Figure Competitive Landscape Analysis of Different Types

    • Table Consumption of Traveler's Diarrhea Therapeutics by Different Types from 2016 to 2027

    • Table Consumption Share of Traveler's Diarrhea Therapeutics by Different Types from 2016 to 2027

    • Figure Market Size and Growth Rate of Immunization

    • Figure Market Size and Growth Rate of Non-antibiotic Agents

    • Figure Market Size and Growth Rate of Antibiotics

    • Figure Market Size and Growth Rate of Anti-Motility Agents

    • Figure Market Size and Growth Rate of Other

    • Table Downstream Client Analysis by End-Users

    • Figure Competitive Landscape Analysis of Different End-Users

    • Table Market Potential Analysis of Different End-Users

    • Figure Consumption of Traveler's Diarrhea Therapeutics by Different End-Users from 2016 to 2027

    • Table Consumption Share of Traveler's Diarrhea Therapeutics by Different End-Users from 2016 to 2027

    • Figure Market Size and Growth Rate of Adult Traveler's Diarrhea

    • Figure Market Size and Growth Rate of Children Traveler's Diarrhea

    • Table USA Traveler's Diarrhea Therapeutics Production by Regions

    • Table USA Traveler's Diarrhea Therapeutics Production Share by Regions

    • Figure USA Traveler's Diarrhea Therapeutics Production Share by Regions in 2016

    • Figure USA Traveler's Diarrhea Therapeutics Production Share by Regions in 2021

    • Figure USA Traveler's Diarrhea Therapeutics Production Share by Regions in 2027

    • Table USA Traveler's Diarrhea Therapeutics Consumption by Regions

    • Table USA Traveler's Diarrhea Therapeutics Consumption Share by Regions

    • Figure USA Traveler's Diarrhea Therapeutics Consumption Share by Regions in 2016

    • Figure USA Traveler's Diarrhea Therapeutics Consumption Share by Regions in 2021

    • Figure USA Traveler's Diarrhea Therapeutics Consumption Share by Regions in 2027

    • Table West USA Traveler's Diarrhea Therapeutics Consumption by Types from 2016 to 2027

    • Table West USA Traveler's Diarrhea Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure West USA Traveler's Diarrhea Therapeutics Consumption Share by Types in 2016

    • Figure West USA Traveler's Diarrhea Therapeutics Consumption Share by Types in 2021

    • Figure West USA Traveler's Diarrhea Therapeutics Consumption Share by Types in 2027

    • Table West USA Traveler's Diarrhea Therapeutics Consumption by End-Users from 2016 to 2027

    • Table West USA Traveler's Diarrhea Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure West USA Traveler's Diarrhea Therapeutics Consumption Share by End-Users in 2016

    • Figure West USA Traveler's Diarrhea Therapeutics Consumption Share by End-Users in 2021

    • Figure West USA Traveler's Diarrhea Therapeutics Consumption Share by End-Users in 2027

    • Table South USA Traveler's Diarrhea Therapeutics Consumption by Types from 2016 to 2027

    • Table South USA Traveler's Diarrhea Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure South USA Traveler's Diarrhea Therapeutics Consumption Share by Types in 2016

    • Figure South USA Traveler's Diarrhea Therapeutics Consumption Share by Types in 2021

    • Figure South USA Traveler's Diarrhea Therapeutics Consumption Share by Types in 2027

    • Table South USA Traveler's Diarrhea Therapeutics Consumption by End-Users from 2016 to 2027

    • Table South USA Traveler's Diarrhea Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure South USA Traveler's Diarrhea Therapeutics Consumption Share by End-Users in 2016

    • Figure South USA Traveler's Diarrhea Therapeutics Consumption Share by End-Users in 2021

    • Figure South USA Traveler's Diarrhea Therapeutics Consumption Share by End-Users in 2027

    • Table Middle West USA Traveler's Diarrhea Therapeutics Consumption by Types from 2016 to 2027

    • Table Middle West USA Traveler's Diarrhea Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure Middle West USA Traveler's Diarrhea Therapeutics Consumption Share by Types in 2016

    • Figure Middle West USA Traveler's Diarrhea Therapeutics Consumption Share by Types in 2021

    • Figure Middle West USA Traveler's Diarrhea Therapeutics Consumption Share by Types in 2027

    • Table Middle West USA Traveler's Diarrhea Therapeutics Consumption by End-Users from 2016 to 2027

    • Table Middle West USA Traveler's Diarrhea Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure Middle West USA Traveler's Diarrhea Therapeutics Consumption Share by End-Users in 2016

    • Figure Middle West USA Traveler's Diarrhea Therapeutics Consumption Share by End-Users in 2021

    • Figure Middle West USA Traveler's Diarrhea Therapeutics Consumption Share by End-Users in 2027

    • Table Northeast USA Traveler's Diarrhea Therapeutics Consumption by Types from 2016 to 2027

    • Table Northeast USA Traveler's Diarrhea Therapeutics Consumption Share by Types from 2016 to 2027

    • Figure Northeast USA Traveler's Diarrhea Therapeutics Consumption Share by Types in 2016

    • Figure Northeast USA Traveler's Diarrhea Therapeutics Consumption Share by Types in 2021

    • Figure Northeast USA Traveler's Diarrhea Therapeutics Consumption Share by Types in 2027

    • Table Northeast USA Traveler's Diarrhea Therapeutics Consumption by End-Users from 2016 to 2027

    • Table Northeast USA Traveler's Diarrhea Therapeutics Consumption Share by End-Users from 2016 to 2027

    • Figure Northeast USA Traveler's Diarrhea Therapeutics Consumption Share by End-Users in 2016

    • Figure Northeast USA Traveler's Diarrhea Therapeutics Consumption Share by End-Users in 2021

    • Figure Northeast USA Traveler's Diarrhea Therapeutics Consumption Share by End-Users in 2027

    • Table Company Profile and Development Status of PaxVax

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of PaxVax

    • Figure Sales and Growth Rate Analysis of PaxVax

    • Figure Revenue and Market Share Analysis of PaxVax

    • Table Product and Service Introduction of PaxVax

    • Table Company Profile and Development Status of Valneva

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Valneva

    • Figure Sales and Growth Rate Analysis of Valneva

    • Figure Revenue and Market Share Analysis of Valneva

    • Table Product and Service Introduction of Valneva

    • Table Company Profile and Development Status of Shanghai United Cell

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Shanghai United Cell

    • Figure Sales and Growth Rate Analysis of Shanghai United Cell

    • Figure Revenue and Market Share Analysis of Shanghai United Cell

    • Table Product and Service Introduction of Shanghai United Cell

    • Table Company Profile and Development Status of P&G

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of P&G

    • Figure Sales and Growth Rate Analysis of P&G

    • Figure Revenue and Market Share Analysis of P&G

    • Table Product and Service Introduction of P&G

    • Table Company Profile and Development Status of Johnson & Johnson

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Johnson & Johnson

    • Figure Sales and Growth Rate Analysis of Johnson & Johnson

    • Figure Revenue and Market Share Analysis of Johnson & Johnson

    • Table Product and Service Introduction of Johnson & Johnson

    • Table Company Profile and Development Status of Livzon

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Livzon

    • Figure Sales and Growth Rate Analysis of Livzon

    • Figure Revenue and Market Share Analysis of Livzon

    • Table Product and Service Introduction of Livzon

    • Table Company Profile and Development Status of Salix Pharmaceuticals

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Salix Pharmaceuticals

    • Figure Sales and Growth Rate Analysis of Salix Pharmaceuticals

    • Figure Revenue and Market Share Analysis of Salix Pharmaceuticals

    • Table Product and Service Introduction of Salix Pharmaceuticals

    • Table Company Profile and Development Status of Immuron

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Immuron

    • Figure Sales and Growth Rate Analysis of Immuron

    • Figure Revenue and Market Share Analysis of Immuron

    • Table Product and Service Introduction of Immuron

    • Table Company Profile and Development Status of Otsuka Pharma

    • Table Sales, Revenue, Sales Price and Gross Margin Analysis of Otsuka Pharma

    • Figure Sales and Growth Rate Analysis of Otsuka Pharma

    • Figure Revenue and Market Share Analysis of Otsuka Pharma

    • Table Product and Service Introduction of Otsuka Pharma


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.